Clinical Trial Update: Linagliptin and Mesenchymal Stem Cells: A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot study investigating linagliptin in combination with mesenchymal stem cells for schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Linagliptin (linagliptin)
• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Nevada, Reno | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED